Commenting on the study for heartwire, antiplatelet expert Dr Victor Serebruany (HeartDrug Research, Towson, MD) said: "This is an extremely important paper with a clear clinical message—abrupt ...

Please provide your email address to receive an email when new articles are posted on . In early 2009, the FDA announced an ongoing safety review of clopidogrel after receiving reports that the use of ...

Early dual antiplatelet therapy shows superior efficacy in reducing stroke recurrence compared with aspirin monotherapy.

Current evidence seems to indicate that due to individual variability in response to clopidogrel, as many as 30% of patients on maintenance clopidogrel (75 mg/day) may show elevated platelet ...

You have full access to this article via your institution. The Clopidogrel as Adjunctive Reperfusion Therapy–Thrombolysis In Myocardial Infarction study (CLARITY-TIMI) 28 trial was an international, ...

In patients who develop a hypersensitivity reaction to clopidogrel soon after stenting, a short course of oral corticosteroids usually allows them to continue the antiplatelet therapy without ...

Combined aspirin and clopidogrel treatment offers greater clinical benefit to patients with acute coronary syndromes (ACS) than aspirin alone, but the financial implications of combined therapy have ...

BARCELONA, Spain—In patients with acute coronary syndromes (ACS), the oral, reversible antiplatelet agent ticagrelor is superior to clopidogrel in reducing ischemic events, without any increase in ...

CHICAGO -- For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more effective and at least as safe as aspirin monotherapy in a high-risk ...

Please provide your email address to receive an email when new articles are posted on . Clopidogrel is one of the most important drugs utilized for secondary prevention of ischemic events in patients ...

Gaspoz et al. (June 6 issue) 1 present an interesting perspective on the problem of escalating health care costs. Their comparison between the cost effectiveness of aspirin and that of clopidogrel is ...

Background: In Canada, access to clopidogrel is restricted by most provincial drug insurance plans in order to contain costs. Until April 2007, the Régie de l'assurance maladie du Québec (RAMQ) ...